Cambridge Investment Research Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Sell |
|
|||||
|
2025
Q1 | $205K | Sell |
|
|||||
|
2024
Q4 | $271K | Sell |
|
|||||
|
2024
Q3 | $390K | Sell |
|
|||||
|
2024
Q2 | $479K | Buy |
|
|||||
|
2024
Q1 | $404K | Sell |
|
|||||
|
2023
Q4 | $558K | Buy |
|
|||||
|
2023
Q3 | $302K | Sell |
|
|||||
|
2023
Q2 | $307K | Sell |
|
|||||
|
2023
Q1 | $303K | Sell |
|
|||||
|
2022
Q4 | $361K | Sell |
|
|||||
|
2022
Q3 | $483K | Sell |
|
|||||
|
2022
Q2 | $412K | Buy |
|
|||||
|
2022
Q1 | $388K | Buy |
|
|||||
|
2021
Q4 | $318K | Sell |
|
|||||
|
2021
Q3 | $566K | Sell |
|
|||||
|
2021
Q2 | $769K | Buy |
|
|||||
|
2021
Q1 | $669K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $228K | Buy |
|
|||||
|
2019
Q3 | $208K | Buy |
|
|||||
|
2019
Q2 | $223K | Sell |
|
|||||
|
2019
Q1 | $285K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $312K | Buy |
|
|||||
|
2018
Q2 | $212K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $247K | Buy |
|
|||||
|
2017
Q2 | $222K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $269K | Sell |
|
|||||
|
2016
Q3 | $229K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $252K | Sell |
|
|||||
|
2015
Q4 | $429K | Sell |
|
|||||
|
2015
Q3 | $327K | Buy |
|
|||||
|
2015
Q2 | $405K | Buy |
|
|||||
|
2015
Q1 | $406K | Sell |
|
|||||
|
2014
Q4 | $450K | Buy |
|
|||||
|
2014
Q3 | $259K | Sell |
|
|||||
|
2014
Q2 | $232K | Buy |
|